Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers September 26, 2017
Pharmacy Choice - News - Front Page Healthcare News - September 26, 2017

Pharmacy News

 Front Page Healthcare News
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

9/25/17 - "Apparatus and Method for Heart Valve Repair" in Patent Application Approval Process (USPTO 20170252160)
By a News Reporter-Staff News Editor at Cardiovascular Week A patent application by the inventor Eidenschink, Tracee, filed on May 24, 2017, was made available online on September 14, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application has not been assigned to a company or institu
9/25/17 - "Medical Devices for Use along the Biliary And/Or Pancreatic Tract" in Patent Application Approval Process (USPTO 20170252189)
By a News Reporter-Staff News Editor at Gastroenterology Week A patent application by the inventors Walsh, Kevin; Petricca, John, filed on May 19, 2017, was made available online on September 14, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application has not been assigned to a compan
9/25/17 - "Method of Treating Neuropathic Pain with a Synergistic Pharmaceutical Composition Comprising Palmitoylethanolamide and L-Acetylcarnitine" in Patent...
"Method of Treating Neuropathic Pain with a Synergistic Pharmaceutical Composition Comprising Palmitoylethanolamide and L-Acetylcarnitine" in Patent Application Approval Process. By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors DELLA VALLE, Francesco; DELLA VALLE, Maria Federica, filed on May 24,
9/25/17 - "Surgical Instruments and Systems Incorporating Machine Learning Based Tissue Identification and Methods Thereof" in Patent Application Approval...
"Surgical Instruments and Systems Incorporating Machine Learning Based Tissue Identification and Methods Thereof" in Patent Application Approval Process. By a News Reporter-Staff News Editor at Robotics& Machine Learning A patent application by the inventor JOHNSON, JOSHUA H., filed on February 28, 2017, was made available online on September 14,
9/25/17 - $9 Bn Disposable Medical Sensors Technologies and Markets, 2022
The "Disposable Medical Sensors: Technologies and Global Markets" report has been added to Research and Markets' offering.. The Global Market for Disposable Medical Sensors Should Reach $5.6 Billion in 2017 and $9.0 Billion by 2022, at a Five-Year CAGR of 10.0% from 2017 to 2022. Regionally, the focus of the study will be the markets of North Ame
9/25/17 - 'Living medicine' cancer therapy starts clinical trials
London- based biopharmaceutical company Autolus is undertaking a novel cancer trial targeting T-cells. The study- which Autolus is calling APRIL- is for its AUTO2 product. Autolus believes that by adding APRIL ligand as a surface protein to the patients T cells it could improve the ability of the body's own immune system to detect and kill cancer c
9/25/17 - 3D Printing Medical Devices Market Report Forecasts Impressive Growth by 2022 - Scalar Market Research
3 D Printing Medical Devices Market Report Forecasts Impressive Growth by 2022 Chicago, IL 09/25/2017 3 D printing is a type of additive manufacturing. It is a process that creates a three-dimensional object using multiple successions of layers. Each new layer connects with the previous ones and continues in similar way until the object forma
9/25/17 - 9 of the Top 15 Medical Device and Diagnostic Companies Move to Veeva Vault
Today at Advamed s 2017 MedTech Conference, Veeva Systems announced that Veeva Vault is helping a growing number of medical device and diagnostics companies improve quality and efficiency to meet new compliance standards. In less than one year, Veeva has seen nearly 25% growth in medical device and diagnostics customers as organizations prepare
9/25/17 - Living medicine' cancer therapy starts clinical trials
London- based biopharmaceutical company Autolus is undertaking a novel cancer trial targeting T-cells. The study which Autolus is calling APRIL is for its AUTO2 product. Autolus believes that by adding APRIL ligand as a surface protein to the patients T cells it could improve the ability of the body's own immune system to detect and kill canc
9/25/17 - AAC Holdings to Increase Payor and Geographic Diversification with Agreement to Acquire AdCare in New England
By a News Reporter-Staff News Editor at Mental Health Weekly Digest AAC Holdings, Inc. announced that it has reached a definitive agreement to acquire AdCare, Inc., its affiliates and associated real estate assets for total consideration of $85 million. AdCare, founded in 1986, is one of the leading providers of addiction treatment in New England
9/25/17 - AbbVie's Upadacitinib ABT-494 Meets All Primary and Ranked Secondary Endpoints in Second Phase 3 Study in Rheumatoid Arthritis
By a News Reporter-Staff News Editor at Clinical Trials Week AbbVie, a global research and development based biopharmaceutical company, announced positive top-line results from the Phase 3 SELECT-BEYOND clinical trial evaluating upadacitinib, an investigational oral JAK1-selective inhibitor, in patients with moderate to severe rheumatoid...
9/25/17 - Acer Therapeutics Reports Positive Results From Pivotal Clinical Trial of EDSIVO? (celiprolol) for Treatment of Vascular Ehlers-Danlos Syndrome
Acer Therapeutics Inc.,, a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and ultra-rare diseases with critical unmet medical need, today announced positive results from the pivotal clinical trial of EDSIVO? for the treatment of vascular Ehlers-Danlos Syndrome. There are curren
9/25/17 - ACORDA THERAPEUTICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Investing In Acorda Therapeutics, Inc. To Contact The Firm
On August 29, 2017, Acorda announced that it had received a Refusal to File letter from the U.S. Food and Drug Administration, which informed the Company that its New Drug Application for INBRIJA "was not sufficiently complete to permit a substantive review." CONTACT: FARUQI& FARUQI, LLP 685 Third Avenue, 26 th Floor New York, NY 10017 Attn: Richar
9/25/17 - Actamax receives approval to begin pivotal clinical trial for Actamax Adhesion Barrier
Release date- 22092017- Actamax Surgical Materials LLC, a wholly owned subsidiary of DSM, focused on design of bioresorbable medical devices to reduce the burden of post-operative complications for patients undergoing surgery, announced it has received conditional approval of an Investigational Device Exemption from the US Food and Drug Administrat
9/25/17 - Aethlon Medical Receives Expedited Access Pathway Designation from FDA to Accelerate U.S. Access to the Hemopurifier as a Treatment for...
Aethlon Medical Receives Expedited Access Pathway Designation from FDA to Accelerate U.S. Access to the Hemopurifier as a Treatment for Life-Threatening Viruses. By a News Reporter-Staff News Editor at Pharma Business Week Aethlon Medical, Inc., a therapeutic technology company focused on unmet needs in global health and biodefense, announced
9/25/17 - After months of furious work, Sen. Bill Cassidy's health care plan faces final test and lengthening odds [The Advocate, Baton Rouge, La.]
Bill Cassidy of Louisiana and his staff will reach a culmination this week in a frenzied final uphill push for votes. Lindsey Graham, R- South Carolina, to repeal and replace the Affordable Care Act, also known as Obamacare, with several Republican colleagues wavering over whether to support the bill just days from a Saturday legislative deadline t
9/25/17 - Agilent Obtains U.S. FDA Approval for GenetiSure Dx Postnatal Assay
By a News Reporter-Staff News Editor at Pharma Business Week Agilent Technologies Inc. has announced that it has obtained 510 clearance from the U.S. Food and Drug Administration for the GenetiSure Dx Postnatal Assay: its first comparative genomic hybridization assay for diagnostic use. Previously available only in Europe, U.S. clinical genetic..
9/25/17 - Agilent Technologies Receives Expanded FDA Approval for the Use of Dako PD-L1 IHC 22C3 pharmDx Companion Diagnostic in Gastric or Gastroesophageal Junction (GEJ) Cancer
SANTA CLARA, Calif. Agilent Technologies Inc. today announced its Dako PD-L1 IHC 22 C3 pharmDx assay has an expanded label approved by U.S. Food and Drug Administration, for use as an aid in identifying gastric or GEJ adenocarcinoma patients for treatment with KEYTRUDA, an anti-PD-1 therapy manufactured by Merck& Co., Inc., Kenilworth, N.J., USA.
9/25/17 - Aldeyra Therapeutics Announces Positive Results from Dry Eye Disease Phase 2a Clinical Trial
By a News Reporter-Staff News Editor at Clinical Trials Week Aldeyra Therapeutics, Inc., a clinical-stage biotechnology company devoted to treating inflammation, inborn errors of metabolism, and other diseases related to endogenous aldehyde toxicity, announced positive results from a Phase 2 a clinical trial of topical ocular ADX-102 in patients
9/25/17 - Allergy Diagnostics Market 2017 - Global Forecast to 2022
The "Allergy Diagnostics Market by Products, Allergens, Tests, End Users- Global Forecast to 2022" report has been added to Research and Markets' offering. The global allergy diagnostics systems market is dominated by North America, followed by Europe. However, Asia is expected to witness the highest CAGR, with the growth in this market centered at
9/25/17 - Allergy Immunotherapy Market Revenue is expected to Reach USD 4,324.7 Million by 2023
Allergy Immunotherapy market information, by allergy type, by treatment- global forecast till 2023. Market Research Future adds new report of "Global Allergy Immunotherapy Market Research Report Forecast to 2023" it contains Company information, geographical data and Table of Content. According to the World Allergy Organization, approximately 10%-4
9/25/17 - AlloSource Announces Milestone In Production Of Bioengineered Blood Vessels For Humacyte's Vascular Access Phase III Clinical Trial
By a News Reporter-Staff News Editor at Clinical Trials Week AlloSource, one of the nation's largest providers of cartilage, bone, skin, soft-tissue and cellular allografts for use in surgical procedures to advance patient healing, announced a major milestone in its partnership with Humacyte. "AlloSource's partnership with Humacyte supports our
9/25/17 - Alnylam Continues Leadership in RNAi Technologies and Delivery with New Pre-Clinical Data Presented on "Enhanced Stabilization Chemistry Plus" (ESC+) GalNAc-siRNA Conjugate Platform at 13th Annual Meeting of the Oligonucleotide Therapeutics Society
Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, today announced that the Company presented new pre-clinical data highlighting its next generation Enhanced Stabilization Chemistry Plus GalNAc-siRNA conjugate platform at the 13 th Annual Meeting of the Oligonucleotide Therapeutics Society, held September 24 27, 2017 in
9/25/17 - Alvogen Subsidiary Confirms ANDA Filing and Patent Challenge for Generic Revlimid
By a News Reporter-Staff News Editor at Pharma Business Week Alvogen subsidiary, Lotus Pharmaceuticals, announced that Celgene filed a suit on 6 September 2017 in the United States District Court for the District of New Jersey. The lawsuit was filed under provisions of the Hatch-Waxman Act, resulting in a stay of final Food and Drug Administratio
9/25/17 - AMD Global Telemedicine Announces Strategic Partnership with Olea Kiosks
AMD Global Telemedicine Inc., the pioneer of clinical Telemedicine Encounter Management Solutions , and Olea Kiosks Inc, the premier global designer and manufacturer of self-service kiosks, announce a partnership to deliver customized kiosks for telehealth applications. "The future of telehealth depends on our ability to make it as convenient an
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415